Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Abeona Therapeutics Inc ABEO

Healthcare Biotechnology
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing cell and gene therapies for life-threatening diseases. The Company’s lead clinical program is for prademagene zamikeracel (pz-cel), its investigational autologous, COL7A1 gene-corrected epidermal sheets currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The... see more

Recent & Breaking News (NDAQ:ABEO)

ABEO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Abeona Therapeutics Inc. and a Lead Plaintiff Deadline of February 14, 2017

GlobeNewswire January 10, 2017

15 Biggest Mid-Day Gainers For Friday

Benzinga.com  January 6, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Abeona Therapeutics Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 14, 2017 – ABEO

GlobeNewswire January 5, 2017

INVESTOR LOSS ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Abeona Therapeutics Inc. - ABEO

GlobeNewswire January 5, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) & Lead Plaintiff Deadline: February 14, 2017

GlobeNewswire January 5, 2017

Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-201 Gene Therapy Program in Juvenile Batten Disease

Marketwired January 3, 2017

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Abeona Therapeutics Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire December 28, 2016

EQUITY ALERT: Rosen Law Firm Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Class Action

Business Wire December 23, 2016

Robbins Arroyo LLP: Abeona Therapeutics Inc. (ABEO) Misled Shareholders According to a Recently Filed Class Action

Business Wire December 23, 2016

Harwood Feffer LLP Announces Investigation of Abeona Therapeutics Inc.

PR Newswire December 22, 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) & Lead Plaintiff Deadline: February 14, 2017

GlobeNewswire December 21, 2016

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Abeona Therapeutics Inc. To Contact The Firm Before Lead Plaintiff Deadline

GlobeNewswire December 20, 2016

SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Abeona Therapeutics Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline – ABEO

GlobeNewswire December 20, 2016

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc.

Business Wire December 20, 2016

SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Abeona Therapeutics Inc. and Advises Investors with Losses to Contact the Firm

Business Wire December 19, 2016

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire December 19, 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Abeona Therapeutics Inc. (ABEO) & Lead Plaintiff Deadline: February 14, 2017

PR Newswire December 19, 2016

INVESTOR LOSS ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Abeona Therapeutics Inc.

Business Wire December 16, 2016

SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire December 13, 2016

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics, Inc.

PR Newswire December 13, 2016